Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?

01.05.25 15:40 Uhr

Werte in diesem Artikel
Aktien

73,70 EUR -0,30 EUR -0,41%

125,55 EUR 2,90 EUR 2,36%

Indizes

PKT PKT

PKT PKT

1.979,6 PKT 47,2 PKT 2,44%

2.045,9 PKT 51,4 PKT 2,58%

23.086,7 PKT 589,7 PKT 2,62%

8.791,3 PKT 206,4 PKT 2,40%

1.820,8 PKT 43,3 PKT 2,43%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

201,6 PKT 0,8 PKT 0,41%

41.317,4 PKT 564,5 PKT 1,39%

552,9 PKT 11,4 PKT 2,11%

12.053,0 PKT 293,0 PKT 2,49%

23.120,0 PKT -4,0 PKT -0,02%

23.092,4 PKT 509,4 PKT 2,26%

16.371,3 PKT -120,1 PKT -0,73%

8.920,7 PKT 223,1 PKT 2,56%

17.575,1 PKT 286,6 PKT 1,66%

2.756,5 PKT 37,3 PKT 1,37%

5.686,7 PKT 82,5 PKT 1,47%

23.111,9 PKT 467,2 PKT 2,06%

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One stock to keep an eye on is Merck KGaA (MKKGY). MKKGY is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A.MKKGY is also sporting a PEG ratio of 1.59. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. MKKGY's PEG compares to its industry's average PEG of 2.08. Over the past 52 weeks, MKKGY's PEG has been as high as 2.31 and as low as 1.40, with a median of 2.07.Another valuation metric that we should highlight is MKKGY's P/B ratio of 0.55. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 1.22. Within the past 52 weeks, MKKGY's P/B has been as high as 0.84 and as low as 0.49, with a median of 0.68.Finally, investors should note that MKKGY has a P/CF ratio of 6.81. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. MKKGY's P/CF compares to its industry's average P/CF of 9.50. Over the past year, MKKGY's P/CF has been as high as 17.18 and as low as 5.99, with a median of 8.37.These are only a few of the key metrics included in Merck KGaA's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, MKKGY looks like an impressive value stock at the moment.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck KGaA (MKKGY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Merck und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Merck

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Merck

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Merck KGaA

Wer­bung

Analysen zu Merck KGaA

DatumRatingAnalyst
02.05.2025Merck BuyDeutsche Bank AG
29.04.2025Merck KaufenDZ BANK
28.04.2025Merck BuyGoldman Sachs Group Inc.
28.04.2025Merck Market-PerformBernstein Research
28.04.2025Merck OverweightJP Morgan Chase & Co.
DatumRatingAnalyst
02.05.2025Merck BuyDeutsche Bank AG
29.04.2025Merck KaufenDZ BANK
28.04.2025Merck BuyGoldman Sachs Group Inc.
28.04.2025Merck OverweightJP Morgan Chase & Co.
25.04.2025Merck BuyUBS AG
DatumRatingAnalyst
28.04.2025Merck Market-PerformBernstein Research
10.04.2025Merck Market-PerformBernstein Research
06.03.2025Merck Market-PerformBernstein Research
07.01.2025Merck Market-PerformBernstein Research
18.10.2024Merck Market-PerformBernstein Research
DatumRatingAnalyst
06.03.2023Merck VerkaufenDZ BANK
02.03.2023Merck SellGoldman Sachs Group Inc.
07.02.2023Merck SellGoldman Sachs Group Inc.
02.02.2023Merck VerkaufenDZ BANK
15.11.2022Merck SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Merck KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen